Core Insights - On October 20, a total of 22 companies had their restricted shares unlocked, with a total unlock volume of 2.095 billion shares, amounting to a market value of 40.69 billion yuan based on the latest closing prices [1] Summary by Category Unlock Volume - The companies with the highest unlock volumes were Shougang Co., Ltd. (10.15 million shares), Sanbai Shuo (1.78 million shares), and Huibo Yuntong (1.57 million shares) [1] Unlock Market Value - The companies with the highest unlock market values were Huibo Yuntong (8.428 billion yuan), Fengcai Technology (7.075 billion yuan), and Shougang Co., Ltd. (4.153 billion yuan) [1] Unlock Ratio - The companies with the highest unlock ratios relative to their total share capital were Sanbai Shuo (72.84%), Yongxin Zhicheng (51.71%), and Bangji Technology (51.03%) [1]

Key Points - The People's Bank of China will announce the latest 1-year and 5-year LPR values on October 20 [1][19] - The National Bureau of Statistics will release macroeconomic data for the third quarter and September on the same day [2][17] - A video call took place between Chinese and U.S. economic leaders, discussing important issues in bilateral economic relations and agreeing to hold new trade consultations soon [4] - The central government has allocated 500 billion yuan to local governments to strengthen fiscal capacity and support economic recovery [4] - The Ministry of Finance announced a VAT policy adjustment for offshore wind power, effective from November 1, 2025, to December 31, 2027, allowing a 50% VAT refund [5] - The Shanghai Stock Exchange reported improved market resilience during the 14th Five-Year Plan, with a 15.9% annualized volatility and an average dividend yield of nearly 2.5% [7] - The Shanghai Stock Exchange aims to enhance the quality of listed companies and attract long-term capital, aligning with national strategies [8] - UBS Wealth Management upgraded its global stock rating to "attractive," citing stronger-than-expected economic growth and easing tariff pressures [9] - A report indicated that the user base for generative AI in China reached 515 million by June 2025, doubling in six months [11] - The domestic market for battery recycling is expected to exceed 100 billion yuan by 2030, with a projected recycling volume of over 300,000 tons in 2024 [12] - Gold prices have significantly declined, with analysts suggesting a greater likelihood of further decreases in the future [13] - Cambricon reported a 2386.38% year-on-year revenue growth for the first three quarters of 2025, driven by market expansion and AI application support [14] - This week, 54 stocks will be unlocked, with a total market value of 71.709 billion yuan, including significant unlocks from Huibo Yuntong and Hengshuai [16] - Citic Securities expects short-term market disturbances from U.S.-China relations to be limited, while Huatai Securities suggests a shift towards defensive sectors [21][22]

Core Viewpoint - Qingdao Sanbai Shuo Health Technology Co., Ltd. is set to release 177,556,827 shares for trading on October 20, 2025, which represents 72.8361% of the company's total share capital [2][21][22]. Group 1: Share Release Details - The number of shares to be released for trading is 177,556,827, accounting for 72.8361% of the total share capital [2][22]. - The total share capital of the company is 243,775,914 shares, with 182,831,935 shares subject to restrictions and 60,943,979 shares freely tradable [4][5]. - The release of shares follows the approval from the China Securities Regulatory Commission and the Shenzhen Stock Exchange [4]. Group 2: Shareholder Commitments - Three shareholders are involved in the release of restricted shares: Qingdao Haishuo Health Industry Development Co., Ltd., J.LU INVESTMENTS LLC, and Ningbo Hechuang Caizhi Investment Partnership [6][23]. - Shareholders have committed to a lock-up period of 36 months from the listing date, during which they will not transfer or manage their shares [6][9]. - If the stock price falls below the initial public offering price for 20 consecutive trading days within the first six months, the lock-up period will be extended by an additional six months [8][9][12]. Group 3: Compliance and Oversight - The company has confirmed that all shareholders have adhered to their commitments regarding the lock-up period and have not engaged in any non-operational use of company funds [20]. - The underwriter, CITIC Securities Co., Ltd., has verified that the release of restricted shares complies with relevant regulations and shareholder commitments [26]. - The company will continue to follow regulations regarding shareholding changes for directors and senior management after the release of shares [25].

（编辑 楚丽君） 证券日报网讯 10月15日晚间，三柏硕发布公告称，公司本次解除限售股份为首次公开发行前已发行的 股份。本次解除限售股份数量为177，556，827股，占公司总股本的72.8361%。本次解除限售股份的上 市流通日：2025年10月20日（星期一）。 ...

（记者 王晓波） 每经AI快讯，三柏硕10月15日晚间发布公告称，公司限售股份约1.78亿股将于2025年10月20日解禁并上 市流通，占公司总股本比例约为72.84%。 每经头条（nbdtoutiao）——出租白银的爆赚机会：年化利率飙升到35%，全球白银正空运往英国套 利，背后是一场史诗级逼空 ...

证券代码：001300 证券简称：三柏硕 公告编号：2025-047 青岛三柏硕健康科技股份有限公司 首次公开发行前已发行股份上市流通的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1.青岛三柏硕健康科技股份有限公司（以下简称"公司"、"本公司"、"三柏 硕"）本次解除限售股份为首次公开发行前已发行的股份。本次解除限售股份数 量为 177,556,827 股，占公司总股本的 72.8361%。 2.本次解除限售股份的上市流通日：2025 年 10 月 20 日（星期一）。 一、首次公开发行前已发行股份概况 经中国证券监督管理委员会《关于核准青岛三柏硕健康科技股份有限公司首 次公开发行股票的批复》（证监许可〔2022〕2054 号）核准，并经深圳证券交易 所《关于青岛三柏硕健康科技股份有限公司人民币普通股股票上市的通知》（深 证上〔2022〕997 号）同意，公司首次公开发行人民币普通股股票 60,943,979 股， 于 2022 年 10 月 19 日在深圳证券交易所主板上市。 首次公开发行前，公司总股本为 182,831,935 ...

关于青岛三柏硕健康科技股份有限公司首次公开发行前 中信建投证券股份有限公司 已发行股份解除限售上市流通的核查意见 中信建投证券股份有限公司（以下简称"中信建投证券"或"保荐机构"） 作为青岛三柏硕健康科技股份有限公司（以下简称"三柏硕"或"公司"）首次 公开发行股票并上市及持续督导的保荐机构，根据《证券发行上市保荐业务管理 办法》《深圳证券交易所股票上市规则》《深圳证券交易所上市公司自律监管指引 第 1 号——主板上市公司规范运作》《深圳证券交易所上市公司自律监管指引第 13 号——保荐业务》等有关规定，对三柏硕首次公开发行前已发行股份解除限 售并上市流通事项进行了核查，具体情况如下： 一、首次公开发行前已发行股份概况 2、本公司在发行人上市前直接或间接持有的发行人股份在上述锁定期满后 两年内减持的，减持价格（如因派发现金红利、送股、转增股本、增发新股等原 因进行除权、除息的，须按照中国证监会、深圳证券交易所的有关规定作相应调 整）不低于首次公开发行价格。 3、三柏硕股票上市后 6 个月内，如三柏硕股票连续 20 个交易日的收盘价（如 因派发现金红利、送股、转增股本、增发新股等原因进行除权、除息的，须按照 中 ...

证券代码：001300 证券简称：三柏硕 公告编号：2025-048 青岛三柏硕健康科技股份有限公司 关于使用部分暂时闲置募集资金进行现金管理的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 青岛三柏硕健康科技股份有限公司（以下简称"公司"）于2025年4月25日 分别召开了第二届董事会第八次会议、第二届监事会第八次会议，审议通过了《关 于使用部分暂时闲置募集资金进行现金管理的议案》，同意在确保不影响募集资 金投资计划正常进行和募集资金安全的情况下，公司使用最高不超过人民币5亿 元的暂时闲置募集资金进行现金管理，使用期限自董事会审议通过之日起12个月 内，单个投资产品的投资期限不超过12个月。额度范围内资金可循环滚动使用。 具体内容详见公司于2025年4月28日披露的《关于使用部分暂时闲置募集资金进 行现金管理的公告》（公告编号：2025-025）。 根据上述决议，公司近期使用闲置募集资金（含现金管理收益和募集资金利息） 购买了部分理财产品，具体事项公告如下： 序 号 申购 主体 交易 对方 产品 名称 产品 类型 金额 （元） 预期年 化收益 起始 ...

Core Viewpoint - Qingdao Sanbai Shuo Health Technology Co., Ltd. has announced its plan to apply for a comprehensive credit limit of up to RMB 800 million from banks and financial institutions for the year 2025, along with related guarantee matters [1] Group 1: Credit Limit and Guarantee Overview - The company plans to apply for a comprehensive credit limit not exceeding RMB 800 million for 2025, which will be used for financing through collateral and guarantees provided by its wholly-owned subsidiaries [1] - The credit limit and guarantee will be valid from the date of approval at the 2024 annual shareholders' meeting until the 2025 annual shareholders' meeting [1] Group 2: Progress of Credit Limit and Guarantee - The company has applied for a comprehensive credit limit of RMB 40 million from China Minsheng Bank Qingdao Branch, with guarantees provided by its wholly-owned subsidiary and the actual controller [2] - The guarantees are irrevocable joint liability guarantees, and no fees will be charged to the company for these guarantees [2] Group 3: Basic Information of the Guaranteed Party - The recent financial indicators of Qingdao Sanbai Shuo Health Technology Co., Ltd. have been audited by a certified public accountant [3] Group 4: Main Content of Guarantee Agreement - The guarantee period is three years from the expiration of the debt performance period, covering principal, interest, penalties, and other related costs [5] Group 5: Board of Directors' Opinion - The board of directors has approved the credit and guarantee matters, confirming they align with the company's actual needs and do not harm the interests of the company and its shareholders [6] Group 6: Cumulative External Guarantee Amount - As of the announcement date, the total external guarantees provided by the company and its subsidiaries amount to RMB 461 million, representing 43.67% of the latest audited net assets [7]

Core Viewpoint - Qingdao Sanbaisuo Health Technology Co., Ltd. announced progress on credit and guarantee, planning to apply for a comprehensive credit limit of up to 800 million yuan by 2025 [1] Group 1: Credit Application - The company and its subsidiaries intend to apply for a comprehensive credit limit of no more than 800 million yuan from financial institutions, with the validity period until the annual general meeting in 2025 [1] - The company has applied for a comprehensive credit limit of 40 million yuan from Minsheng Bank Qingdao Branch, guaranteed by its wholly-owned subsidiary Haishuo Fitness and actual controller Zhu Xilong, without any fees or counter-guarantees [1] Group 2: Guarantee and Financial Status - As of the announcement date, the total amount of external guarantees provided by the company and its subsidiaries is 46.1 million yuan, accounting for 43.67% of the most recent audited net assets [1] - All guarantees are within the consolidated financial statements, with no overdue or abnormal situations reported [1]